The drug discount program is under scrutiny on a variety of fronts ...

Washingtonians are struggling to afford already high health care costs, and those costs keep climbing. Sadly, I’ve seen this ...

The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing for providers participating in the 340B drug discount program.

The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more ...

A new report paints a stark picture of how a subset of large healthcare providers are drawing the lion’s share of 340B savings within a single state.  | A Minnesota analysis of providers' reported ...

A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy of choice.

The Health Resources and Services Administration Feb. 25 said it will extend the deadline to April 20 to receive comments on ...

AHA urges HHS to block Novo Nordisk's 340B data demand, citing legal and cost concerns for safety-net hospitals and covered entities.

AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.

Hospitals and contract pharmacies are not required to pass those savings directly to patients at the pharmacy counter. | ...

On April 28, AEI’s Kirsten Axelsen hosted the former North Carolina Department of Health and Human Services Secretary Kody Kinsley; Anthony DiGiorgio of the University of California, San Francisco; ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...